Literature DB >> 22181047

Intra-arterial delivery of cell therapies for stroke.

Vivek Misra1, Aditya Lal, Ramy El Khoury, Peng R Chen, Sean I Savitz.   

Abstract

Cell therapy is a novel investigational approach to enhance stroke recovery. Intra-arterial (IA) delivery has the potential advantage of selectively targeting cell therapies to the ischemic brain tissue. Over the past 10 years, IA cell delivery has been under investigation in patients with cardiac and peripheral vascular disease, and these studies have reported promising results. This article reviews the trial methodology and procedural details of these studies and discusses the rationale and challenges in designing IA cell therapy trials for ischemic stroke.

Entities:  

Mesh：

Year:  2012        PMID： 22181047      PMCID： PMC3328761          DOI： 10.1089/scd.2011.0612

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN： 1547-3287            Impact factor:   3.272


  55 in total

1.  Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.

Authors:  Gerd P Meyer; Kai C Wollert; Joachim Lotz; Jan Steffens; Peter Lippolt; Stephanie Fichtner; Hartmut Hecker; Arnd Schaefer; Lubomir Arseniev; Bernd Hertenstein; Arnold Ganser; Helmut Drexler
Journal:  Circulation       Date:  2006-03-06       Impact factor: 29.690

2.  The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model.

Authors:  Sang Yup Lim; Yong Sook Kim; Youngkeun Ahn; Myung Ho Jeong; Moon Hwa Hong; Soo Yeon Joo; Kwang Il Nam; Jeong Gwan Cho; Peter M Kang; Jong Chun Park
Journal:  Cardiovasc Res       Date:  2006-03-06       Impact factor: 10.787

3.  The effect of transcatheter injections on cell viability and cytokine release of mononuclear cells.

Authors:  R El Khoury; V Misra; S Sharma; C S Cox; P Walker; J C Grotta; A Gee; S Suzuki; S I Savitz
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-15       Impact factor: 3.825

4.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Authors:  Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

5.  Endovascular treatment of medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage.

Authors:  P Jun; N U Ko; J D English; C F Dowd; V V Halbach; R T Higashida; M T Lawton; S W Hetts
Journal:  AJNR Am J Neuroradiol       Date:  2010-07-08       Impact factor: 3.825

6.  Intravenous autologous bone marrow mononuclear cells for ischemic stroke.

Authors:  Sean I Savitz; Vivek Misra; Mallik Kasam; Harrinder Juneja; Charles S Cox; Susan Alderman; Imo Aisiku; Siddhartha Kar; Adrian Gee; James C Grotta
Journal:  Ann Neurol       Date:  2011-07       Impact factor: 10.422

7.  Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction.

Authors:  Jay H Traverse; David H McKenna; Karen Harvey; Beth C Jorgenso; Rachel E Olson; Nancy Bostrom; Diane Kadidlo; John R Lesser; Vikrant Jagadeesan; Ross Garberich; Timothy D Henry
Journal:  Am Heart J       Date:  2010-09       Impact factor: 4.749

8.  Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial.

Authors:  Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Nikos Werner; Jürgen Haase; Jörg Neuzner; Alfried Germing; Bernd Mark; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal:  Eur Heart J       Date:  2006-11-10       Impact factor: 29.983

9.  Intra-arterial fibrinolytic therapy in central retinal artery occlusion.

Authors:  M Schumacher; D Schmidt; A K Wakhloo
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

10.  Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia.

Authors:  R B Van Tongeren; J F Hamming; W E Fibbe; V Van Weel; S J G C Frerichs; A M Stiggelbout; J H Van Bockel; J H Lindeman
Journal:  J Cardiovasc Surg (Torino)       Date:  2008-02       Impact factor: 1.888
View more
  10 in total

Review 1.  Developing Cellular Therapies for Stroke.

Authors:  Sean I Savitz
Journal:  Stroke       Date:  2015-06-04       Impact factor: 7.914

2.  Overexpression of VLA-4 in glial-restricted precursors enhances their endothelial docking and induces diapedesis in a mouse stroke model.

Authors:  Anna Jablonska; Daniel J Shea; Suyi Cao; Jeff Wm Bulte; Miroslaw Janowski; Konstantinos Konstantopoulos; Piotr Walczak
Journal:  J Cereb Blood Flow Metab       Date:  2017-04-24       Impact factor: 6.200

Review 3.  The rise of cell therapy trials for stroke: review of published and registered studies.

Authors:  Paulo Henrique Rosado-de-Castro; Pedro Moreno Pimentel-Coelho; Lea Mirian Barbosa da Fonseca; Gabriel Rodriguez de Freitas; Rosalia Mendez-Otero
Journal:  Stem Cells Dev       Date:  2013-04-25       Impact factor: 3.272

4.  A Detailed Assessment of Varying Ejection Rate on Delivery Efficiency of Mesenchymal Stem Cells Using Narrow-Bore Needles.

Authors:  Mahetab H Amer; Felicity R A J Rose; Lisa J White; Kevin M Shakesheff
Journal:  Stem Cells Transl Med       Date:  2016-01-29       Impact factor: 6.940

5.  Devices for cell transplantation into the central nervous system: Design considerations and emerging technologies.

Authors:  Matthew B Potts; Matthew T Silvestrini; Daniel A Lim
Journal:  Surg Neurol Int       Date:  2013-03-19

6.  The effect of injection using narrow-bore needles on mammalian cells: administration and formulation considerations for cell therapies.

Authors:  Mahetab H Amer; Lisa J White; Kevin M Shakesheff
Journal:  J Pharm Pharmacol       Date:  2015-01-26       Impact factor: 3.765

Review 7.  Translational considerations in injectable cell-based therapeutics for neurological applications: concepts, progress and challenges.

Authors:  Mahetab H Amer; Felicity R A J Rose; Kevin M Shakesheff; Michel Modo; Lisa J White
Journal:  NPJ Regen Med       Date:  2017-08-10

8.  Feasibility and Efficacy of Intra-Arterial Administration of Mesenchymal Stem Cells in an Animal Model of Double Toxin-Induced Multiple System Atrophy.

Authors:  Ha Na Kim; Dong Yeol Kim; Se Hee Oh; Hyung Sook Kim; Kyung Suk Kim; Phil Hyu Lee
Journal:  Stem Cells Transl Med       Date:  2017-03-13       Impact factor: 6.940

9.  A biomaterials approach to influence stem cell fate in injectable cell-based therapies.

Authors:  Mahetab H Amer; Felicity R A J Rose; Kevin M Shakesheff; Lisa J White
Journal:  Stem Cell Res Ther       Date:  2018-02-21       Impact factor: 6.832

10.  Peripheral Delivery of Neural Precursor Cells Ameliorates Parkinson's Disease-Associated Pathology.

Authors:  George Edwards Iii; Nazaret Gamez; Enrique Armijo; Carlos Kramm; Rodrigo Morales; Kathleen Taylor-Presse; Paul E Schulz; Claudio Soto; Ines Moreno-Gonzalez
Journal:  Cells       Date:  2019-10-30       Impact factor: 6.600
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.